MCK - McKesson Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
170.78
+2.77 (+1.65%)
At close: 4:04PM EST

170.76 -0.02 (-0.01%)
After hours: 4:28PM EST

Stock chart is not supported by your current browser
Previous Close168.01
Open168.20
Bid168.00 x 800
Ask175.00 x 1200
Day's Range167.02 - 171.22
52 Week Range110.52 - 171.22
Volume2,911,913
Avg. Volume1,663,401
Market Cap30.216B
Beta (5Y Monthly)1.13
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.64 (0.98%)
Ex-Dividend DateFeb 27, 2020
1y Target EstN/A
All
News
Press Releases
  • Business Wire

    McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare

    McKesson Corporation (NYSE:MCK) today announced the commencement of an exchange offer for the split-off of its wholly-owned subsidiary, PF2 SpinCo, Inc. ("SpinCo"), which will hold all of McKesson’s interest in Change Healthcare LLC ("Change Healthcare"), as part of McKesson’s previously announced agreement with Change Healthcare Inc. (Nasdaq:CHNG) ("Change") to merge SpinCo with and into Change.

  • Business Wire

    McKesson Reports Fiscal 2020 Third Quarter Results

    McKesson Corporation (NYSE:MCK) today reported results for the third quarter ended December 31, 2019.

  • ACCESSWIRE

    McKesson Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 4, 2020 / McKesson Corp. (NYSE:MCK) will be discussing their earnings results in their 2020 Third Quarter Earnings to be held on February 4, 2020 at 8:00 AM Eastern ...

  • Business Wire

    McKesson Declares Quarterly Dividend

    The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 41 cents per share of common stock. The dividend will be payable on April 1, 2020, to stockholders of record on March 2, 2020.

  • Business Wire

    McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook

    McKesson Corporation (NYSE:MCK) will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco tomorrow, January 14, 2020 at 9:00 AM PT (12:00 PM ET). Brian Tyler, chief executive officer of McKesson, will provide a company overview and review topics including:

  • Business Wire

    McKesson Corporation to Announce Third Quarter Fiscal 2020 Results on February 4, 2020

    McKesson Corporation (NYSE:MCK) announced today that its third quarter fiscal 2020 financial results will be released before market open on Tuesday, February 4, 2020. The company will host a conference call at 8:00 AM Eastern Time to discuss the financial results.

  • GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Meredith Corporation, McKesson Corporation, Maxar Technologies, and ViewRay and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Meredith Corporation (MDP), McKesson Corporation (MCK), Maxar Technologies, Inc. (MAXR), and ViewRay, Inc. (VRAY) on behalf of long-term stockholders. Bragar Eagel & Squire is investigating certain officers and directors of Meredith Corporation following a class action complaint that was filed against Meredith Corporation on September 6, 2019.

  • PR Newswire

    McKesson (MCK) Alert: Johnson Fistel Announces Shareholder Class Action Against McKesson Corporation Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?

    SAN DIEGO, Nov. 8, 2019 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of McKesson Corporation (MCK) ("McKesson" or the "Company") against certain of its officers and directors. Recently, a class action lawsuit pending in the United States District Court for the Northern District of California against McKesson and certain of its executives survived Defendants' attempts to have the case dismissed. The case arises out of whether McKesson and certain of its executives made materially false and misleading statements and omissions regarding the Company's financial performance and its generics business.

  • Business Wire

    McKesson Corporation to Announce First Quarter Fiscal 2020 Results on July 31, 2019

    McKesson Corporation (MCK) announced today that its first quarter fiscal 2020 financial results will be released on Wednesday, July 31, 2019 following the close of market. The company will host a conference call at 5:00 PM Eastern Time (2:00 PM Pacific Time) the same day to discuss the financial results. A live audio webcast of the conference call will be available on McKesson’s Investor Relations website at http://investor.mckesson.com, along with the company’s earnings press release, financial tables and slide presentation.

  • Business Wire

    McKesson Issues Statement on Change Healthcare IPO

    Change Healthcare, Inc., a scaled healthcare information technology company, began trading on the Nasdaq Global Select Market under the trading symbol "CHNG." McKesson holds the majority ownership stake in Change Healthcare’s operating subsidiary. "Congratulations to Change Healthcare on this significant milestone in the company’s history. For McKesson, this is an important next step in our efforts to unlock value for McKesson shareholders from our investment in the Change Healthcare business," said Brian Tyler, chief executive officer of McKesson.

  • Business Wire

    McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director

    McKesson Corporation (MCK) today announced that its board of directors elected Dr. Ken Washington as a new independent director, effective July 1, 2019. With the election of Dr. Washington, McKesson’s board of directors increases from nine to ten members, nine of whom are independent. “Ken’s years of experience in technology, research, and privacy strategy at complex global organizations will be invaluable to the board as we maintain oversight of the company and provide the leadership team with strategic guidance,” said Edward Mueller, McKesson’s independent board chair.

  • Business Wire

    CORRECTING and REPLACING McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results

    IRVING, Texas-- -- Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%. Fourth-quarter GAAP loss per diluted share from continuing operations of $ and full-year GAAP earnings per diluted share from continuing operations of $0.17. Fourth-quarter Adjusted Earnings per diluted share of $3.69, up 6% from a year ago. Full-year ...

  • Business Wire

    McKesson Reaches Settlement With State of West Virginia on Opioid Order Monitoring and Reporting

    McKesson Corporation (MCK) today announced that it has settled litigation with the State of West Virginia to resolve all claims regarding McKesson’s operations in the state. Under the terms of the agreement, McKesson will pay $14.5 million to the State this year and an additional $4.5 million per year for the next five years. Funds from the settlement are to be used in support of state initiatives to combat the opioid epidemic, including rehabilitation, job training, mental health and other important efforts.

  • Business Wire

    McKesson Appoints Tracy Faber to Top HR Role

    Jorge Figueredo and Kathy McElligott to retire

  • Business Wire

    McKesson Declares Quarterly Dividend April 24, 2019

    The Board of Directors of McKesson Corporation today declared a regular dividend of thirty-nine cents per share on Common Stock. The dividend will be payable on July 1, 2019, to stockholders of record on June 3, 2019.